These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Complications and 5-year survival after radical resections which include urological organs for locally advanced and recurrent pelvic malignancies: analysis of 646 consecutive cases. Peacock O; Waters PS; Kong JC; Warrier SK; Wakeman C; Eglinton T; Murphy DG; Heriot AG; Frizelle FA; McCormick JJ Tech Coloproctol; 2020 Feb; 24(2):181-190. PubMed ID: 31907722 [TBL] [Abstract][Full Text] [Related]
26. Assessing the impact of a sacral resection on morbidity and survival after extended radical surgery for locally recurrent rectal cancer. Milne T; Solomon MJ; Lee P; Young JM; Stalley P; Harrison JD Ann Surg; 2013 Dec; 258(6):1007-13. PubMed ID: 23364701 [TBL] [Abstract][Full Text] [Related]
27. Pelvic exenteration: a review of current issues/controversies. Shine RJ; Glyn T; Frizelle F ANZ J Surg; 2022 Nov; 92(11):2822-2828. PubMed ID: 35490337 [TBL] [Abstract][Full Text] [Related]
28. Pelvic Exenteration Surgery: The Evolution of Radical Surgical Techniques for Advanced and Recurrent Pelvic Malignancy. Brown KGM; Solomon MJ; Koh CE Dis Colon Rectum; 2017 Jul; 60(7):745-754. PubMed ID: 28594725 [TBL] [Abstract][Full Text] [Related]
29. Sacral resection for control of pelvic tumors. Temple WJ; Ketcham AS Am J Surg; 1992 Apr; 163(4):370-4. PubMed ID: 1373043 [TBL] [Abstract][Full Text] [Related]
30. Laparoscopic combined transperitoneal pelvic exenteration for vulvovaginal recurrence of rectal carcinoma following a Miles operation. Zhang H; Tang J; Wei Z; Wang D; Wang R; Xiao L Tech Coloproctol; 2022 Jun; 26(6):495-496. PubMed ID: 34973070 [No Abstract] [Full Text] [Related]
31. Excellent Outcomes After Extended Radical Pelvic Resection for Locally Advanced and Recurrent IBD-Associated Anorectal Cancer. Chang KH; Brown KGM; Chen Lau Y; Solomon MJ Dis Colon Rectum; 2021 Feb; 64(2):209-216. PubMed ID: 33315717 [TBL] [Abstract][Full Text] [Related]
32. ASO Author Reflections: Major Morbidity After Extended Radical Resections for Locally Advanced and Recurrent Pelvic Malignancies. Peacock O; Waters PS; Frizelle FA; McCormick JJ Ann Surg Oncol; 2020 Feb; 27(2):415-416. PubMed ID: 31686345 [No Abstract] [Full Text] [Related]
33. Validation of MRI and Surgical Decision Making to Predict a Complete Resection in Pelvic Exenteration for Recurrent Rectal Cancer. Brown WE; Koh CE; Badgery-Parker T; Solomon MJ Dis Colon Rectum; 2017 Feb; 60(2):144-151. PubMed ID: 28059910 [TBL] [Abstract][Full Text] [Related]
35. Feasibility of transperineal minimal invasive surgery when performing sacrectomy for advanced primary and recurrent pelvic malignancies. Beppu N; Ito K; Otani M; Imada A; Matsubara T; Song J; Kimura K; Kataoka K; Kuwahara R; Horio Y; Uchino M; Ikeuchi H; Ikeda M Tech Coloproctol; 2024 Jul; 28(1):80. PubMed ID: 38971941 [TBL] [Abstract][Full Text] [Related]
36. Indications and outcome of pelvic exenteration for locally advanced primary and recurrent rectal cancer. Bhangu A; Ali SM; Brown G; Nicholls RJ; Tekkis P Ann Surg; 2014 Feb; 259(2):315-22. PubMed ID: 23478530 [TBL] [Abstract][Full Text] [Related]
37. Feasibility of transanal minimally invasive surgery for total pelvic exenteration for advanced primary and recurrent pelvic malignancies. Beppu N; Ito K; Otani M; Imada A; Matsubara T; Song J; Kimura K; Kataoka K; Kuwahara R; Horio Y; Uchino M; Ikeuchi H; Ikeda M Tech Coloproctol; 2023 Dec; 27(12):1367-1375. PubMed ID: 37878167 [TBL] [Abstract][Full Text] [Related]
38. Total pelvic exenteration for primary locally advanced and locally recurrent rectal cancer. Vermaas M; Ferenschild FT; Verhoef C; Nuyttens JJ; Marinelli AW; Wiggers T; Kirkels WJ; Eggermont AM; de Wilt JH Eur J Surg Oncol; 2007 May; 33(4):452-8. PubMed ID: 17071043 [TBL] [Abstract][Full Text] [Related]
39. Pelvic exenteration and composite sacral resection in the surgical treatment of locally recurrent rectal cancer. Gawad W; Khafagy M; Gamil M; Fakhr I; Negm M; Mokhtar N; Lotayef M; Mansour O J Egypt Natl Canc Inst; 2014 Sep; 26(3):167-73. PubMed ID: 25150132 [TBL] [Abstract][Full Text] [Related]
40. ASO Author Reflections: Pelvic Exenteration for Patients with Primary and Recurrent Pelvic Cancer. Kulu Y Ann Surg Oncol; 2019 May; 26(5):1350. PubMed ID: 30843159 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]